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Dr. Gerald Meyer Emphasizes “Courage” at the American Society of
Health System Pharmacists
The following is an excerpt of an inaugural
address given by Gerald E. Meyer,
PharmD, MBA, FASHP, new President of
the American Society of Health System
Pharmacists (ASHP), at the Opening
Session of ASHP’s Summer Meeting in
Minneapolis, MN, June 4, 2013. Included
in this excerpt are highlights from questions
submitted from ASHP members. Dr. Meyer
is Director of Experiential Education at the
Jefferson School of Pharmacy.
I would like to begin by acknowledging
you—our members. I want to personally
thank all of the members who have
participated in ASHP’s state societies.
ASHP could not fulfill its mission without
the support and inspired leadership of our
affiliates. Yes, being president of ASHP
involves a lot of time and travel. But it also
comes with a large support staff.
The volunteer leaders in our affiliates,
on the other hand, do it all. You are the
membership committee, the program
committee, the finance committee, the
professional advocacy committee, the
strategic planning committee, and so much
more. So, to all of you, a great big thanks!
A Rich Pharmacy History
Many of you may know that I am from
Philadelphia. And I am proud of it.
Philadelphia has a very rich pharmacy
history. We have the first hospital in the
United States—Pennsylvania Hospital —
founded by Benjamin Franklin in 1751.
We have the first college of pharmacy
in the United States—the Philadelphia
College of Pharmacy, which opened
in 1821. And we had the first hospital
pharmacist in the United States. His name
was Jonathan Roberts.

We also lay claim to the first Hospital
Pharmacy Residency Program to be
surveyed for ASHP accreditation and
the first accredited Pharmacy Technician
Training Program, both at Thomas
Jefferson University Hospital.
We have four past-presidents of ASHP
currently working in Philadelphia and a
fifth in retirement nearby. I have been truly
fortunate to have had access to so many
health-system pharmacy leaders.
I am most appreciative for the inspiration,
support, and encouragement that I have
received from numerous professional
colleagues – including more than 230
pharmacy residents – at Thomas Jefferson
University Hospital and Thomas Jefferson
University with whom I have had the
privilege to work. And, most importantly,
I am thankful for the wonderful personal
support from my wife, Cheryl, my sons
Kevin and David, and many family
members and friends.
Top Priorities
In writing this speech, I definitely had a
lot of people to call upon. Yet, as much
as I value their wisdom, I did not ask a
single one of them for guidance on what
I should talk about today. Rather, I asked
you, the members. ASHP is a membership
organization. It is owned by you, its
members. So I felt it was appropriate to
focus our discussion today on those issues
that are of greatest importance to you.
We sent out a survey to a random sample
of ASHP members and asked: “What
question would you like to ask Gerry
Meyer?” Well, you did not disappoint. We
received 130 questions, many of which
spoke to the concept of courage.

“What will be your top priorities as
incoming president of ASHP?”
I have a list of priorities to share with you.
But my priorities are of little value unless
they become our priorities. My top priority,
therefore, is to be the best leader I can possibly
be. And you can’t lead without a vision.
What makes a good leader?
•T
 he ability to articulate a vision,
•T
 he ability to motivate others toward
that vision, and
•T
 he ability to remove obstacles to
promote achievement of the vision.
Now, who among you can recite ASHP’s
vision? ASHP’s vision is that medication
use will be optimal, safe and effective
for all people, all of the time. There’s no
mention of “hospitals” or “health systems.”
There’s not even mention of “patients.” It
says “all people, all of the time.”
Here is my list of priorities for the year. I
would suggest that we view most of the
individual items on this list as obstacles
confronting us in our efforts to accomplish
ASHP’s vision:
•B
 uild coalitions
• I mplement the recommendations of the
Pharmacy Practice Model Initiative
•P
 ursue provider status
•P
 romote interprofessional education
and practice
•E
 xpand training and certification for
pharmacists and pharmacy technicians
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•P
 osition ASHP to be as nimble
as possible in a rapidly changing
environment, and…
•W
 orld peace!
There’s a reason for the last item on
the list. Creating an environment in
which medication use will be optimal,
safe and effective for all people, all of
the time is a bold and expansive
vision. And just because it is hard to
conceptualize, we cannot be deterred
from putting our energies towards its
achievement. (So, in that respect, our
vision is a bit like world peace.)
Antagonism vs. Synergism
“We see a push to work collaboratively
with other health care providers but seem
to have a difficult time putting this into
practice. Are there ways to accelerate
this interprofessional practice? Perhaps
through pharmacy education and postgraduate residency programs?”
By definition, interprofessional activities
clearly cannot be accomplished by one
profession. Each profession must be
willing to participate.
The good news is that in May 2011,
a group called the Interprofessional
Education Collaborative—consisting
of educators representing pharmacy,
medicine, nursing, dentistry, and public
health—released a report that summarized
the core competencies needed for
interprofessional collaborative practice.
Those core competencies fell within
four domains:
1. Values and ethics
2. Roles and responsibilities
3. Interprofessional communication
4. Teams and teamwork

What this report says is that to build an
efficient and effective health care system,
health care providers need to:
•H
 ave a common understanding of
health care ethics and values
•U
 nderstand one another’s roles and
responsibilities
•L
 earn how to communicate with one
another, and
•L
 earn how to be part of effective
teams and how to play well together
in the sandbox.
For two years, we have had this guidance
document that delineates the curricular
components that should be taught to
health care students, interprofessionally.
Our profession needs to take a leadership
position in incorporating interprofessional
competencies into our formal education
and training standards. These changes
cannot occur fast enough. Furthermore, to
develop this set of skills and knowledge
within practicing pharmacists, ASHP
must incorporate this critical content
within our continuing professional
development offerings.
It’s important to consider what this
report does not say. Nowhere does it say
that interprofessional education should
encompass getting health care students
into the same classroom to teach them
pathophysiology, pharmacology, diagnosis,
or treatment. So, if those are not our
commonalities, then those must be our
differences. Exactly.
Let’s look at this in pharmacologic terms.
Sometimes, we administer two very
effective drugs that may compete for
the same receptor, and the result is that
they become less effective. We call that
phenomenon “antagonism.” On the other
hand, sometimes we prescribe two drugs
and the positive effect is greater than the
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anticipated sum of their individual effects.
We call that “synergism.”
Let’s move past interprofessional
antagonism. Let’s have the courage to
promote an efficient and effective health
care system comprised of interdependent,
synergistic health care providers.
The Future of Residency Training
Among the questions I received, more
related to residencies than to any other
topic. Two members asked: “How does
ASHP plan to help grow the number of
residency programs and the number of
available positions? And, how can the
accreditation process be simplified?”
Although it sometimes may feel like we
are making little progress in this area, the
numbers tell a different story. From 1995
to 2006 (a 12-year period), the number of
available accredited residency programs
and the number of available positions in
those programs doubled. From 2006 to
2012 (a subsequent 6-year period), the
number of accredited residency programs
and number of positions doubled again.
Part of the reason for this rapid growth is
that the value proposition for residencies is
easily developed for residents, employers,
patients, and the profession. The ASHP
website contains a number of documents
that can assist practitioners in justifying,
designing, and conducting residency
training programs.
However, one of the greatest barriers to
increasing the number of residency training
programs cannot be overcome with
guidance documents alone. A good training
program requires a solid infrastructure.
Pharmacy services must meet
contemporary standards of practice.
Preceptors must have the ability to impart
knowledge and develop critical reasoning
skills. Residency program directors
Continued on next page
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must be able to mentor and inspire
those entering the profession. And an
organization’s culture must be supportive
of the training mission. We cannot, and
we should not, compromise on these
foundational pillars.
While ASHP’s residency policy is
aspirational in nature and the decision
about whether to pursue a residency is
a career decision and you do not need a
residency to obtain a pharmacist license;
you do need a residency to pursue and
advance along certain career paths and the
number of those career paths continues to
grow every year.
There are four stages to the education
and continued training of a pharmacist:
pre-pharmacy undergraduate education,
professional doctorate education,
formalized training, and continuing
professional development. Coordinating
the outcomes of each of these four stages
is a professional imperative. Yes; the
requirements for the pre-pharmacy and
pharmacy curricula will continue to
evolve; but, we must recognize that there
is only so much that we can accomplish
in the classroom because (1) contact time
is limited, and (2) students do not have
pharmacist licenses.
At some point in time, the profession
will need to address the question: Should
residency training be required for
pharmacists to meet their obligation to
their patients? At some point, that answer
will be “yes.” Whether this happens
by 2020 or not, it is far better for the
profession to prepare for that future than to
be unprepared when that future arrives.
Gaining Provider Status
“When are pharmacists finally going to
be recognized as providers, and what will
it change?”
Many of you may have attended the
Provider Status Town Hall at this Summer

Meeting where this very issue was
discussed. Much of what we heard, we
already knew:
•T
 he health care environment is changing.
•E
 merging practice models are focused on
integrated health care delivery systems.
•P
 olicymakers are seeking ways to
make health care more affordable for
more people.
•P
 ayment will be focused on quality,
not quantity, of care.
•C
 onsumers will demand transparency
in the cost of their care.
So, what will happen when pharmacists
are recognized as health care providers?
•P
 harmacists’ patient care services will
improve access.
•P
 harmacists’ patient care services will
improve quality.
•P
 harmacists’ patient care services
will help control costs. Access—
quality—cost. There is substantial
documentation to support the positive
impact of pharmacists on access,
quality and cost of care. We know it.
Now we have to sell it. We must have
the courage of our convictions.
The first step towards achieving provider
status is to ensure that the profession
moves forward with this common
message by solidifying these basic
principles within the existing coalition of
pharmacy organizations. Then, we need
to expand the coalition to include other
critical stakeholders, including health
care provider groups, payers, and patient
advocates. We need to draft legislation and
seek support by educating legislators, both
on a state and national level.
ASHP will serve as your collective voice
in formulating the message. ASHP will
develop the materials needed to deliver that
message. ASHP will tailor those materials
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for different audiences. And ASHP will train
you. But, we need you to deliver the message
to your legislators, to your C-suite, to your
health-system’s lobbyists, to your health care
colleagues, to your complacent pharmacist
colleagues, to your local media, and to
your patients. Access—quality—cost. The
message is clear. The message is focused.
The message meets society’s needs.
Gaining provider status will ensure that
pharmacy is at the table when regulators
and other policymakers invite health care
providers to help construct new delivery
models. And that is why ASHP, the American
Pharmacists Association (APhA), the
American College of Clinical Pharmacy
(ACCP), and other health care organizations
have committed significant resources to
achieving provider status for pharmacists.
While no one can predict when we will
finally succeed, I am confident that we will
succeed if we have the courage to stand
strong and united on this issue and if our
members get personally involved.
I call upon all pharmacists who believe they
are health care providers, on all student
pharmacists who believe they are training
to become health care providers, on all
people who want their medication use to be
optimal, safe and effective all of the time.
I call on everyone to send the message:
“Pharmacists are medication-use experts.
Pharmacists improve access, improve
quality, and control the cost of health care.
Pharmacists are health care providers.”
In closing, I want to thank everyone who
took the time to submit questions. I invite
you to continue to send me your comments
and suggestions over the next year. Send
your emails to: prez@ashp.org.
Finally, I want to thank you for the courage
you show every day toward advancing
ASHP’s vision: that medication use will be
optimal, safe and effective for all people,
all of the time. 

